当前位置:首页 - 行情中心 - 哈药股份(600664) - 财务分析 - 现金流量表

哈药股份

(600664)

  

流通市值:70.27亿  总市值:70.34亿
流通股本:25.19亿   总股本:25.21亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金15,581,300,699.3411,629,792,337.477,664,935,820.893,799,327,621.47
收到的税费返还1,906,424.661,024,359.37533,442.68382,988.9
收到其他与经营活动有关的现金439,369,911.9361,259,167.84286,180,659.32222,701,041.53
经营活动现金流入的平衡项目0000
经营活动现金流入小计16,022,577,035.911,992,075,864.687,951,649,922.894,022,411,651.9
购买商品、接受劳务支付的现金10,889,436,909.548,082,487,490.455,274,144,696.012,708,489,734.54
支付给职工以及为职工支付的现金1,368,402,005.031,014,943,593.28717,306,892.35403,384,183.86
支付的各项税费817,627,080.36586,680,664.5435,996,079.15240,140,104.18
支付其他与经营活动有关的现金1,997,440,066.81,502,446,155.24992,737,887.53487,772,537.69
经营活动现金流出的平衡项目0000
经营活动现金流出小计15,072,906,061.7311,186,557,903.477,420,185,555.043,839,786,560.27
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额949,670,974.17805,517,961.21531,464,367.85182,625,091.63
二、投资活动产生的现金流量:
收回投资收到的现金-498,000--
取得投资收益收到的现金589,474.35589,474.35--
处置固定资产、无形资产和其他长期资产收回的现金净额35,938,620.0335,455,108.582,004,6701,861,330
投资活动现金流入的平衡项目0000
投资活动现金流入小计36,528,094.3836,542,582.932,004,6701,861,330
购建固定资产、无形资产和其他长期资产支付的现金86,535,472.1740,341,056.8425,531,553.3116,203,695.8
支付其他与投资活动有关的现金156,636,691.86157,134,691.86--
投资活动现金流出的平衡项目0000
投资活动现金流出小计243,172,164.03197,475,748.725,531,553.3116,203,695.8
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-206,644,069.65-160,933,165.77-23,526,883.31-14,342,365.8
三、筹资活动产生的现金流量:
吸收投资收到的现金3,725,5202,575,4202,566,120807,640
取得借款收到的现金3,207,013,676.981,387,800,000850,000,000600,000,000
收到其他与筹资活动有关的现金448,970,20058,000,00058,000,00050,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计3,659,709,396.981,448,375,420910,566,120650,807,640
偿还债务支付的现金3,384,491,193.671,397,236,216.3891,436,216.3561,000,000
分配股利、利润或偿付利息支付的现金44,156,175.3133,243,324.6623,179,136.7912,823,858.31
支付其他与筹资活动有关的现金83,119,950.7149,570,373.4730,923,747.0414,118,144.34
筹资活动现金流出平衡项目0000
筹资活动现金流出小计3,511,767,319.691,480,049,914.43945,539,100.13587,942,002.65
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额147,942,077.29-31,674,494.43-34,972,980.1362,865,637.35
四、汇率变动对现金及现金等价物的影响923,881.92,433,589.662,739,863.9975,315.14
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额891,892,863.71615,343,890.67475,704,368.4231,223,678.32
加:期初现金及现金等价物余额2,064,246,391.392,064,246,391.392,064,246,391.392,064,246,391.39
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,956,139,255.12,679,590,282.062,539,950,759.792,295,470,069.71
补充资料:
净利润474,218,172.89-221,348,136.43-
资产减值准备45,066,567.23-13,667,807.16-
固定资产和投资性房地产折旧223,052,746.69-112,076,544.94-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧223,052,746.69-112,076,544.94-
无形资产摊销36,778,480.12-16,437,431.57-
长期待摊费用摊销7,556,841.55-3,067,520.93-
处置固定资产、无形资产和其他长期资产的损失-1,333,760.51--1,511,780.08-
固定资产报废损失357,529.41-326,939.91-
财务费用56,261,351.83-26,635,074.5-
投资损失-4,483,228.47---
递延所得税2,966,220.34-611,640.23-
其中:递延所得税资产减少2,340,526.47-611,640.23-
递延所得税负债增加625,693.87---
存货的减少-119,585,196.96--33,355,940.45-
经营性应收项目的减少-94,415,810.36--264,659,823.45-
经营性应付项目的增加245,208,417.1-401,387,204.09-
不涉及现金收支的投资和筹资活动金额其他项目33,946,306.68---
现金的期末余额2,956,139,255.1-2,539,950,759.79-
减:现金的期初余额2,064,246,391.39-2,064,246,391.39-
公告日期2024-04-112023-10-272023-08-252023-04-28
审计意见(境内)标准无保留意见
TOP↑